testosterone enanthate has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilowski, W; Krysiak, R; Okopień, B | 2 |
| Brune, M; Nieschlag, E; Zitzmann, M | 1 |
| Barrett-Connor, EL | 1 |
1 review(s) available for testosterone enanthate and Cardiovascular Diseases
| Article | Year |
|---|---|
Testosterone and risk factors for cardiovascular disease in men.
Topics: Adult; Aged; Anabolic Agents; Cardiovascular Diseases; Cholesterol, HDL; Clinical Trials as Topic; Humans; Male; Risk Factors; Stanozolol; Testosterone | 1995 |
3 other study(ies) available for testosterone enanthate and Cardiovascular Diseases
| Article | Year |
|---|---|
The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Hypogonadism; Injections, Intramuscular; Male; Metformin; Middle Aged; Risk Factors; Sulfonylurea Compounds; Testosterone; Treatment Outcome | 2016 |
The effect of testosterone on cardiometabolic risk factors in atorvastatin-treated men with late-onset hypogonadism.
Topics: Aged; Atorvastatin; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Drug Therapy, Combination; Humans; Hypogonadism; Lipids; Male; Metabolic Diseases; Middle Aged; Risk Factors; Testosterone; Treatment Outcome; Uric Acid | 2016 |
Vascular reactivity in hypogonadal men is reduced by androgen substitution.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Brachial Artery; Cardiovascular Diseases; Cholesterol; Chorionic Gonadotropin; Endothelium, Vascular; Estradiol; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypogonadism; Insulin-Like Growth Factor I; Linear Models; Male; Middle Aged; Testosterone; Triglycerides; Ultrasonography; Vasodilation | 2002 |